Prognostic value of baseline 18F-FDG PET/CT metabolic parameters combined with clinical and pathological features in surgically resected ALK-positive non-small cell lung cancer | Synapse
March 3, 2026
Prognostic value of baseline 18F-FDG PET/CT metabolic parameters combined with clinical and pathological features in surgically resected ALK-positive non-small cell lung cancer
Key Points
Increased metabolic parameters correlate with poorer prognosis in patients.
A significant finding was the differentiation between prospective survival rates.
Observational analysis of clinical features and pathological data provided insights.
Implies the need for further validation in diverse clinical settings.